- Home
- OCGN vs CBAN Comparison
OCGN vs CBAN Comparison
Compare OCGN & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- CBAN
- Stock Information
- Founded
- OCGN 2013
- CBAN 1975
- Country
- OCGN United States
- CBAN United States
- Employees
- OCGN N/A
- CBAN N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- CBAN Major Banks
- Sector
- OCGN Health Care
- CBAN Finance
- Exchange
- OCGN Nasdaq
- CBAN Nasdaq
- Market Cap
- OCGN 283.3M
- CBAN 279.6M
- IPO Year
- OCGN N/A
- CBAN 1998
- Fundamental
- Price
- OCGN $1.05
- CBAN $16.44
- Analyst Decision
- OCGN Strong Buy
- CBAN
- Analyst Count
- OCGN 3
- CBAN 0
- Target Price
- OCGN $6.00
- CBAN N/A
- AVG Volume (30 Days)
- OCGN 2.6M
- CBAN 60.9K
- Earning Date
- OCGN 08-01-2025
- CBAN 07-23-2025
- Dividend Yield
- OCGN N/A
- CBAN 2.80%
- EPS Growth
- OCGN N/A
- CBAN 24.13
- EPS
- OCGN N/A
- CBAN 1.57
- Revenue
- OCGN $4,754,000.00
- CBAN $118,533,000.00
- Revenue This Year
- OCGN N/A
- CBAN $18.25
- Revenue Next Year
- OCGN N/A
- CBAN $7.59
- P/E Ratio
- OCGN N/A
- CBAN $10.46
- Revenue Growth
- OCGN N/A
- CBAN 8.33
- 52 Week Low
- OCGN $0.52
- CBAN $13.89
- 52 Week High
- OCGN $1.40
- CBAN $18.49
- Technical
- Relative Strength Index (RSI)
- OCGN 53.85
- CBAN 48.30
- Support Level
- OCGN $1.01
- CBAN $15.86
- Resistance Level
- OCGN $1.07
- CBAN $16.94
- Average True Range (ATR)
- OCGN 0.05
- CBAN 0.36
- MACD
- OCGN 0.00
- CBAN 0.01
- Stochastic Oscillator
- OCGN 66.48
- CBAN 47.54
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.